Trials Near Add Your Location

Accepting patients

ELEMENT-MDS

Phase 3 Clinical Trial Comparing Luspatercept VS Epoetin Alfa in Patients with Very Low – Intermediate Risk MDS Who Are Not Transfusion Dependent
Learn more
  • Erythroid Maturation Agent (EMA)
  • Erythropoiesis-Stimulating Agent (ESA)
  • Red Blood Cell Stimulant
  • Phase 3

Accepting patients

Bone Marrow & Kidney Transplant

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)
Learn more
  • Allogeneic Stem Cell Transplant
  • Phase 2
Get personalized results in 60 seconds
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials

Accepting patients

Identifying Barriers to Allo Stem Cell Transplants

Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Learn more
  • Pre-Allogeneic Stem Cell Transplant
  • Observational Trial

Accepting patients

Smart Immune

Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Acute Leukemia After T Cell Depleted Allo-HSCT
Learn more
  • Phase 1/2

Accepting patients

Antibiotics During Stem Cell Transplant

Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant
Learn more
  • Allogeneic Stem Cell Transplant
  • Phase 2

Accepting patients

PTSD Mobile App

PTSD Mobile App for Cancer Survivors
Learn more
  • Observational Trial

Accepting patients

SEA-CD70

A Phase 1 Study of SEA-CD70 in Myeloid Malignancies
Learn more
  • Monoclonal Antibody
  • Phase 1

Not yet accepting

NEXI-001

Phase 1b Expansion Study of Multi-Antigen Specific CD8+ T Cells After Decitabine-enhanced Lymphodepletion: an Adoptive Cellular Therapy for Patients with Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Transplantation from Matched HLA Donors
Learn more
  • Allogeneic Stem Cell Transplant
  • T Cell (Allogeneic)
  • Post-Allogeneic Stem Cell Transplant
  • Phase 1

Not yet accepting

Lisaftoclax

A Global Multicenter, Double-blind, Randomized, Registrational Phase 3 Study of Lisaftoclax (APG-2575) in Combination With Azacitidine (AZA) in Patients With Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS) (GLORA-4).
Learn more
  • BCL-2 Inhibitor
  • Placebo
  • Randomization
  • Phase 3

Accepting patients

PROMISE

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
Learn more
  • High Risk
  • Observational
  • Observational Trial